Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 12.92
- Piotroski Score 3.00
- Grade Buy
- Symbol (OLMA)
- Company Olema Pharmaceuticals, Inc.
- Price $12.48
- Changes Percentage (1.22%)
- Change $0.15
- Day Low $12.05
- Day High $12.50
- Year High $17.79
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer. The company was formerly known as CombiThera, Inc. and changed its name to Olema Pharmaceuticals, Inc. in March 2009. Olema Pharmaceuticals, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/04/2024
- Fiscal Year End N/A
- Average Stock Price Target $27.00
- High Stock Price Target $30.00
- Low Stock Price Target $24.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$2.00
- Trailing P/E Ratio -6.56
- Forward P/E Ratio -6.56
- P/E Growth -6.56
- Net Income $-96,655,000
Income Statement
Quarterly
Annual
Latest News of OLMA
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
I have the ideal road plan for Britain. Take the 16 major highway schemes worth £15bn and bin them | Christian Wolmar
New ministers must choose between continuing with costly road-building projects or embracing sustainable alternatives to drive growth and combat climate change. Scrapping unnecessary road schemes coul...
By The Guardian | 1 week ago -
Sing Sing review - Colman Domingo is magnetic in moving real-life US prison drama
Colman Domingo shines in Greg Kwedar's prison drama "Sing Sing," where former inmates make up the cast. The film explores the transformative power of art and the unlikely friendship between convicts, ...
By The Guardian | 1 week ago -
Sing Sing review - Colman Domingo is larger than life in big-hearted prison musical
Based on a real-life project teaching theater to inmates, this film captures charm and energy. Domingo's standout performance as an inmate differs from the rest, providing an intriguing contrast. The ...
By The Guardian | 3 weeks ago